Clinical Trials in Phoenix

Showing 7241-7260 of 16,646 trials

Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)

NCT03433807

The primary objective of this Expanded Access Program is to provide idebenone as a treatment for eligible participants with Duchenne Muscular Dystrophy before it is commercially available in the United States (U.S.) for the indication of DMD.

Duchenne Muscular Dystrophy

Santhera Pharmaceuticals

Phoenix, Arizona, United States • New Haven, Connecticut, United States • Chicago, Illinois, United States +9 more locations

UNKNOWNNA< 1 mile

Targeted Muscle Reinnervation Study (TMR)

NCT05408520

The purpose of this study is to examine the effect of targeted muscle reinnervation on the outcomes of amputees at a level 1 trauma center. The investigators propose to randomize all patients requiring amputation with and without targeted muscle reinnervation. This study will help delineate the efficacy of targeted muscle reinnervation in the general population.

Amputation

Joshua Hustedt50 participantsStarted May 2023

Phoenix, Arizona, United States

Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)

Targeted Muscle Reinnervation Study (TMR)

Find Trials by Condition in Phoenix

Reducing Dietary Added-Sugar Consumption During the Transition to College

Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy

Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence

Randomized Trial in Adult Participants With Acute Migraines

A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer

A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia

Relative Bioavailability of LY03010 Compared to Listed Drug

A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery

Safety, Tolerability, and Pharmacokinetics of CAL056 Mesylate in Patients With Resistant or Refractory Solid Tumors

Rapid Diagnostics for HIV and Hepatitis

tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden

A Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis

A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.

An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of EQ143

A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease

FreeStyle Libre 2 Discharge Trial

Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults